Series B funding round for Sigilon Therapeutics raising $80M in March 2020
Series B funding round for Sigilon Therapeutics raising $80M in March 2020
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Angel | Eli Lilly | |
| Angel | Timothy A. Springer |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$80M
Top Valuation
-
Sigilon Therapeutics raised $80M in a Series B round.
The round was announced on 03/01/20.
The round was led by Flagship Ventures.